Evidence map›Paper›PMID 42326778›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Mortality in people with attention-deficit/hyperactivity disorder (ADHD): Examining how risk is embodied in a pooling of two prospective cohort studies.

Haibin Li, Tamsin Ford, Varun Warrier, Steven Bell, G David Batty

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haibin LiDepartment of Cardiology and Medical Research Center, Beijing Chaoyang Hospital, Capital Medical University, Beijing, CN.ORCID 0000-0002-6932-982X
Tamsin FordDepartment of Psychiatry, University of Cambridge, Cambridge, UK.ORCID 0000-0001-5295-4904
Varun WarrierDepartment of Psychiatry, University of Cambridge, Cambridge, UK.ORCID 0000-0003-4532-8571
Steven BellDepartment of Behavioural Science and Health, University College London, London, UK.ORCID 0000-0001-6774-3149
G David BattyDepartment of Epidemiology and Public Health, University College London, London, UK.ORCID 0000-0003-1822-5753

Funding

Healthy transitions from mid-life to early older age: biomedical follow-up of 1958 Birth Cohort Study members at age 60R01AG052519 · NIA · UNIVERSITY COLLEGE LONDON · PI BATTY, DAVID, GOODMAN, ALISSA · 2017 to 2021
$1.9M
Healthy transitions from mid-life to early older age: biomedical follow-up of 1958 Birth Cohort Study members at age 60R56AG052519 · NIA · UNIVERSITY COLLEGE LONDON · PI BATTY, DAVID, GOODMAN, ALISSA · 2016 to 2016
$500k
NIA NIH HHS R01 AG052519NIA NIH HHS R56 AG052519
6 · The paper itself

Abstract

Background: Nascent findings suggest that people with attention-deficit/hyperactivity disorder (ADHD) experience higher rates of mortality. To date, study samples have been insufficiently well-characterized to examine the mechanisms via which this neurodevelopmental condition elevates mortality risk. Methods: We used data from the 2007 and 2011 waves of the US National Health Interview Survey, a general population-based cohort study comprising 52097 adults (28675 women) aged 18 years or older at baseline. ADHD diagnosis and an array of demographic, socioeconomic, lifestyle, and co-morbidity (somatic and psychiatric) covariates were self-reported. Findings: At baseline, compared with unaffected individuals, participants with ADHD were more likely to be socioeconomically disadvantaged, smoke cigarettes, consume alcohol, and report symptoms of psychological distress. A median 7.75 years of mortality surveillance (range: 7.25-12.25) gave rise to 6597 deaths from all-causes. After adjustment for age, sex, ethnicity, and survey year, ADHD was associated with a markedly elevated risk of death (hazard ratio [95% confidence interval]: 1.58 [1.20-2.09]). Statistical adjustment for socioeconomic circumstances (11% attenuation), physical co-morbidities (15%), and lifestyle factors (17%) had only a modest impact on the ADHD-death gradient, with the greatest explanatory power apparent for symptoms of depression and anxiety (58%). The magnitude of the association of ADHD with mortality was commensurate to that for several well-established risk factors such as poverty (1.66 [1.55-1.78]), hypertension (1.41 [1.32-1.51]), and diabetes (1.71 [1.59-1.85]) but somewhat lower than cigarette smoking (2.51 [2.29-2.76]) after controlling for age, sex, ethnicity, and survey year. Associations between ADHD and cause-specific mortality from cardiovascular disease, cancer, and chronic respiratory disease were inconclusive. Interpretation: In the present study, the influence of ADHD on total mortality appears to be largely embodied via a series of malleable characteristics, particularly mental illness. If confirmed elsewhere, these results raise the possibility that risk factor modification via standard pharmacological and behavioral interventions could help reduce rates of premature mortality in this patient group.

Identifiers

PMID42326778
PMCPMC13278226

What Socratic holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.